Equitec Proprietary Markets’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-56,557
Closed -$52.6K 164
2022
Q4
$52.6K Sell
56,557
-45,300
-44% -$60.4K 0.02% 96
2022
Q3
$173K Sell
101,857
-59,900
-37% -$157K 0.05% 97
2022
Q2
$346K Hold
161,757
0.1% 86
2022
Q1
$574K Sell
161,757
-333,618
-67% -$967K 0.13% 57
2021
Q4
$1.84M Buy
495,375
+285,775
+136% +$1.75M 0.25% 42
2021
Q3
$1.55M Buy
209,600
+193,000
+1,163% +$1.65M 0.29% 43
2021
Q2
$221K Buy
+16,600
New +$163K 0.07% 96

Other funds holding CLOV

Equitec Proprietary Markets's CLOV Position: Q1 2023 in Review

Equitec Proprietary Markets sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 56,557 shares — an estimated $52.6K sold.

Equitec Proprietary Markets first reported a position in CLOV in Q2 2021 and held it in 7 quarters. The position peaked at $1.84M in Q4 2021. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

  • Equitec Proprietary Markets reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
  • Equitec Proprietary Markets sold 56,557 Clover Health Investments shares in Q1 2023, an estimated $52.6K.
  • Equitec Proprietary Markets first reported a position in Clover Health Investments in Q2 2021 and held it in 7 quarters.
  • Equitec Proprietary Markets's Clover Health Investments position peaked at $1.84M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on Equitec Proprietary Markets's 13F filing for Q1 2023, filed 28 Apr 2023.